@FierceMedDev: SV Bio changes name to Lifecode, plans rollout of NGS cancer assay. FierceDiagnostics story | Follow @FierceMedDev
@VarunSaxena2: Celator's delivery platform results in FDA's fast-track designation for its cancer candidate. FierceDrugDelivery article | Follow @VarunSaxena2
@EmilyWFierce: J&J settles the score with over 100 vaginal mesh plaintiffs. More | Follow @EmilyWFierce
> LabCorp ($LH) has raised $2.9 billion in debt to help finance its acquisition of contract research organization Covance ($CVD) for $5.6 billion that was announced in early November. The deal is slated to close during the first quarter. Release
> CareFusion ($CFN) shareholders have approved the $12.2 billion acquisition proposed by Becton, Dickinson and Company ($BDX) in early October with 76% of shares cast for approval. The deal is expected to close during the first half of 2015. Release
> Microsoft ($MSFT) has unveiled its 3D holographic glasses, HoloLens. They are expected to have multiple applications, including surgical training. Story
> AliveCor has received a CE mark for its automated analysis algorithm to detect atrial fibrillation (AF). It analyzes electrocardiogram recordings made by its smartphone plug-in device and automatically notifies the user if AF has been detected. Release
Biotech News
@FierceBiotech: China's Innovent banks $100M to cash in on the biosimilar boom. Report | Follow @FierceBiotech
@JohnCFierce: So Martin Pule, who got his start with Brenner at Baylor on CAR-T ($CELG, $BLUE) went on the Cellectis deal ($ALCLS) is now CSO at Autolous. | Follow @JohnCFierce
@DamianFierce: @IAmBiotech weighs in on Obama's precision medicine plan. More | Follow @DamianFierce
> Kite expands its immuno-oncology brain trust in the CAR-T footrace. Article
> The CAR-T brain war: Scientific trailblazer inspires a $45M biotech startup. Story
Pharma News
@FiercePharma: Report: Livestock research lab prioritizes profits over animal health. FierceAnimalHealth article | Follow @FiercePharma
@EricPFierce: UK's MHRA expands its ban of Wockhardt's plant in Chikalthana, India to include all APIs. FiercePharmaManufacturing article | Follow @EricPFierce
@CarlyHFierce: Incoming Takeda chief ready to jump on the M&A train with reorg in place. Report | Follow @CarlyHFierce
> Rooting for a French CEO at Sanofi? Take another name off your list of prospects. Story
> Novartis eyes psoriasis dominance with new approvals for Cosentyx. Article
Vaccines News
> After rocky flu season, vaccinemakers may want to follow Novartis' lead. Story
> Disneyland measles outbreak adds fuel to heated anti-vaccination debate. Item
> J&J forms consortia to accelerate Ebola vaccine development, gets €100M boost from IMI. News
> Study: GSK's malaria vaccine may not be effective when used with bed nets. More
> MSF urges GSK, Pfizer to slash pneumococcal vaccine prices. Report
Pharma Manufacturing News
> Manufacturing key to getting more effective flu jabs to market faster. Story
> Gulf Pharmaceutical commits to sterile injectable plant in Ethiopia. Report
> FDA finds more counterfeit Cialis, warns consumers. Article
> U.K. expands Wockhardt ban. More
> Biologics manufacturing helps Lonza to early turnaround. Story